Angel Wang is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. Her practice focuses on patent prosecution, strategic patent counseling, patent portfolio management, and IP due diligence, including freedom-to-operate and patent validity/invalidity analyses. Angel has worked on patent-related matters in a variety of technical subject areas, including CRISPR gene editing, antibody, epigenetic editing, cancer immunology, small molecule drugs, cosmetics, xenotransplantation, RNA technology, neuroscience, adeno-associated virus (AAV) vectors delivery, and microbiology.
Prior to joining the firm, Angel was an associate at a Washington, D.C., law firm where she focused on preparing patent applications and responses to office actions, managing patent portfolios, reviewing foreign patent filings, and drafting instructions to foreign associates.
Angel’s technical expertise includes microbiology, molecular biology, biochemistry, and genetics. During her doctoral studies at Clark University, she conducted scientific research on the impact of heavy metal on the antioxidant defenses of bacteria.
Angel Wang is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. Her practice focuses on patent prosecution, strategic patent counseling, patent portfolio management, and IP due diligence, including freedom-to-operate and patent validity/invalidity analyses. Angel has worked on patent-related matters in a variety of technical subject areas, including CRISPR gene editing, antibody, epigenetic editing, cancer immunology, small molecule drugs, cosmetics, xenotransplantation, RNA technology, neuroscience, adeno-associated virus (AAV) vectors delivery, and microbiology.
Prior to joining the firm, Angel was an associate at a Washington, D.C., law firm where she focused on preparing patent applications and responses to office actions, managing patent portfolios, reviewing foreign patent filings, and drafting instructions to foreign associates.
Angel’s technical expertise includes microbiology, molecular biology, biochemistry, and genetics. During her doctoral studies at Clark University, she conducted scientific research on the impact of heavy metal on the antioxidant defenses of bacteria.
- The George Washington University Law School, 2018
With Honors; Associate, The George Washington Law Review; Member, Student Intellectual Property Law Association
- Ph.D., Biology, Clark University, 2015
- B.S., Biotechnology, Nanjing Agricultural University, 2010
- State Bar of Massachusetts
- U.S. Patent and Trademark Office (Limited recognition to practice under 37 CFR § 11.9(b))
- The George Washington University Law School, 2018
With Honors; Associate, The George Washington Law Review; Member, Student Intellectual Property Law Association
- Ph.D., Biology, Clark University, 2015
- B.S., Biotechnology, Nanjing Agricultural University, 2010
- State Bar of Massachusetts
- U.S. Patent and Trademark Office (Limited recognition to practice under 37 CFR § 11.9(b))
Select Publications:
- Co-author, “Gene Therapy Policies Can Strike An Ethical Balance,” Law360, May 3, 2019
- Co-author, “New USPTO Guidance May help Diagnostics Patents,” Law360, April 22, 2019
- Co-author, “Mercury reduction and methyl mercury degradation by the soil bacterium Xanthobacter autotrophicus Py2,” 81(22) Applied and Environmental Microbiology 7833-7838, 2015
- Co-author, “The impact of ionic mercury on antioxidant defenses in two mercury-sensitive anaerobic bacteria,” 26(6) BioMetals 1023-1031, 2013
Select Publications:
- Co-author, “Gene Therapy Policies Can Strike An Ethical Balance,” Law360, May 3, 2019
- Co-author, “New USPTO Guidance May help Diagnostics Patents,” Law360, April 22, 2019
- Co-author, “Mercury reduction and methyl mercury degradation by the soil bacterium Xanthobacter autotrophicus Py2,” 81(22) Applied and Environmental Microbiology 7833-7838, 2015
- Co-author, “The impact of ionic mercury on antioxidant defenses in two mercury-sensitive anaerobic bacteria,” 26(6) BioMetals 1023-1031, 2013
Biological Sciences and Biotechnology
- Antibody
- Biologics
- Cancer biology
- Cancer therapeutics
- CAR-T cells
- Cell biology
- Epigenetics
- Immuno-oncology
- Microbiology
- Molecular biology
- Neurobiology
- T and B cell biology
- T cell biology
- T cell immunology
Therapeutics and Drug Discovery
- Biosimilars
- CRISPR
- Drug delivery
- Gene editing
- Gene therapy
- Vaccines
Biological Sciences and Biotechnology
- Antibody
- Biologics
- Cancer biology
- Cancer therapeutics
- CAR-T cells
- Cell biology
- Epigenetics
- Immuno-oncology
- Microbiology
- Molecular biology
- Neurobiology
- T and B cell biology
- T cell biology
- T cell immunology
Therapeutics and Drug Discovery
- Biosimilars
- CRISPR
- Drug delivery
- Gene editing
- Gene therapy
- Vaccines
- Privacy Policy
- Terms of Use
- Accessibility